Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Bionow BioAI Summit

The Bionow BioAI Summit is a brand-new event designed to explore the fast-growing intersection of artificial intelligence and life sciences. As AI continues to transform [...]

2025 BioCap Conference

The BioCap Conference is a unique gathering that connects life sciences companies, researchers, and investors under one roof. It offers the chance to explore today’s [...]

BioNow 2025 Oncology Conference

Join Bionow and leading voices in oncology at the 2025 Oncology Conference, a pivotal event focused on innovation in cancer research and treatment. This full-day [...]

Go to Top